SCHEMBL22490879

SCHEMBL22490879

CCO[C@H]1C(O)O[C@H](COC(=O)c2ccc(OCc3ccccc3)cc2)[C@@H](O)[C@@H]1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.48
CHRNA5 P30532 1/20 0.48
CHRNA7 P36544 1/20 0.48
CHRNA4 P43681 1/20 0.48
MAOB P27338 1/20 0.44
PARP10 Q53GL7 1/20 0.44
NR4A1 P22736 1/20 0.43
NR4A2 P43354 1/20 0.43
NR4A3 Q92570 1/20 0.43
ADRB2 P07550 1/20 0.43
ADRB1 P08588 1/20 0.43
ADRB3 P13945 1/20 0.43
LMNA P02545 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SRD5A2 P31213 1/20 0.41
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22490912 0.90 CHRNB2 (0.50) CHRNB2CHRNA5CHRNA7CHRNA4MAOB
SCHEMBL22490872 0.90 CHRNB2 (0.50) CHRNB2CHRNA5CHRNA7CHRNA4MAOB
SCHEMBL22490932 0.90 CHRNB2 (0.50) CHRNB2CHRNA5CHRNA7CHRNA4MAOB
SCHEMBL22490901 0.87 CHRNB2 (0.44) CHRNB2CHRNA5CHRNA7CHRNA4MAOB
SCHEMBL23488460 0.87 CHRNB2 (0.49) CHRNB2CHRNA5CHRNA7CHRNA4MAOB
SCHEMBL22490902 0.86 CHRNB2 (0.52) CHRNB2CHRNA5CHRNA7CHRNA4MAOB
SCHEMBL23488604 0.84 CHRNB2 (0.53) CHRNB2CHRNA5CHRNA7CHRNA4MAOB
SCHEMBL23488173 0.84 CHRNB2 (0.53) CHRNB2CHRNA5CHRNA7CHRNA4MAOB
SCHEMBL23488459 0.82 CHRNB2 (0.49) CHRNB2CHRNA5CHRNA7CHRNA4MAOB
SCHEMBL23488262 0.81 CHRNB2 (0.51) CHRNB2CHRNA5CHRNA7CHRNA4MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed
EP-3717463-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN Sanofi (FR) 2020-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 CHRNB2 3085/4885CHRNA5 3785/4885CHRNA7 4025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.